Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B E Maryanoff

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Journal of Pharmaceutical Sciences|April 1, 1978
Stereochemical considerations in structural comparison of enkephalins and endorphins with exogenous opiate agentsB E Maryanoff, M J Zelesko
Journal of Medicinal Chemistry|February 1, 1983
Replacement of aromatic or heteroaromatic groups in nonsteroidal antiinflammatory agents with the ferrocene groupB E Maryanoff, S L Keeley, F J Persico
Journal of Medicinal Chemistry|March 1, 1985
The pKa of butaclamol and the mode of butaclamol binding to central dopamine receptorsF A Chrzanowski, B A McGrogan, B E Maryanoff
Epilepsia|April 18, 2000
Topiramate as an inhibitor of carbonic anhydrase isoenzymesS J Dodgson, R P Shank, B E Maryanoff
Journal of Medicinal Chemistry|August 1, 1984
Structure-activity studies on antidepressant 2,2-diarylethylaminesB E Maryanoff, S O Nortey, J F Gardocki
Carbohydrate Research|March 7, 1998
Synthesis of hydroxylated derivatives of topiramate, a novel antiepileptic drug based on D-fructose: investigation of oxidative metabolitesS O Nortey, W N Wu, B E Maryanoff
Journal of Medicinal Chemistry|August 1, 1982
Potential affinity labels for the opiate receptor based on fentanyl and related compoundsB E Maryanoff, E J Simon, T Gioannini, et al.
Journal of the American Chemical Society|December 20, 2011
Correction. stereochemistry of the wittig reaction. Effect of nucleophillic groups in phosphonium ylideB E Maryanoff, A B Reitz, B A Duhl-Emswiler
Bioorganic & Medicinal Chemistry Letters|February 18, 1999
Photoactivatable peptides based on BMS-197525: a potent antagonist of the human thrombin receptor (PAR-1)J T Elliott, W J Hoekstra, B E Maryanoff, et al.
Epilepsia|April 18, 2000
An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of actionR P Shank, J F Gardocki, A J Streeter, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Journal of Pharmaceutical Sciences|April 1, 1978
Stereochemical considerations in structural comparison of enkephalins and endorphins with exogenous opiate agentsB E Maryanoff, M J Zelesko
Journal of Medicinal Chemistry|February 1, 1983
Replacement of aromatic or heteroaromatic groups in nonsteroidal antiinflammatory agents with the ferrocene groupB E Maryanoff, S L Keeley, F J Persico
Journal of Medicinal Chemistry|March 1, 1985
The pKa of butaclamol and the mode of butaclamol binding to central dopamine receptorsF A Chrzanowski, B A McGrogan, B E Maryanoff
Epilepsia|April 18, 2000
Topiramate as an inhibitor of carbonic anhydrase isoenzymesS J Dodgson, R P Shank, B E Maryanoff
Journal of Medicinal Chemistry|August 1, 1984
Structure-activity studies on antidepressant 2,2-diarylethylaminesB E Maryanoff, S O Nortey, J F Gardocki
Carbohydrate Research|March 7, 1998
Synthesis of hydroxylated derivatives of topiramate, a novel antiepileptic drug based on D-fructose: investigation of oxidative metabolitesS O Nortey, W N Wu, B E Maryanoff
Journal of Medicinal Chemistry|August 1, 1982
Potential affinity labels for the opiate receptor based on fentanyl and related compoundsB E Maryanoff, E J Simon, T Gioannini, et al.
Journal of the American Chemical Society|December 20, 2011
Correction. stereochemistry of the wittig reaction. Effect of nucleophillic groups in phosphonium ylideB E Maryanoff, A B Reitz, B A Duhl-Emswiler
Bioorganic & Medicinal Chemistry Letters|February 18, 1999
Photoactivatable peptides based on BMS-197525: a potent antagonist of the human thrombin receptor (PAR-1)J T Elliott, W J Hoekstra, B E Maryanoff, et al.
Epilepsia|April 18, 2000
An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of actionR P Shank, J F Gardocki, A J Streeter, et al.
Pageof 5